Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

Rx Ltd.APPENDIX TO CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS(UNAUDITED)Convenience translationinto USDNine months ended September 30,Nine months endedSeptember 30,201220132013NIS in thousandsIn thousandsAdjustments required to reflect net cash used in operating
activities: Income and expenses not involving cash flows: Depreciation and amortization

1,188

870

246Impairment of intangible assets

-

138

39Long-term prepaid expenses

(17)

60

17Exchange differences on cash and cash equivalents

(4,931)

1,988

562Share-based compensation

2,358

2,400

678Warrant issuance costs

1,204

470

133Gain on adjustment of warrants to fair value

(5,528)

(10,191)

(2,881)Interest and exchange differences on short-term deposits

1,726

1,521

431Interest and linkage on bank loan

(21)

(10)

(3)Interest and exchange differences on restricted deposits

(31)

30

8(4,052)

(2,724)

(770)Changes in operating asset and liability items:Decrease in trade accounts receivable andother receivables

2,193

1,374

388Increase (decrease) in accounts payable and accruals

1,135

(8,487)

(2,400)3,328

(7,113)

(2,012)(724)

(9,837)

(2,782)Supplementary information on interest received in cash1,439

449

127 


'/>"/>
SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... , Oct. 16, 2014 The ... guidance on the application of single-use, or ... pharmaceutical and biopharmaceutical products with the publication ... Application of Single-Use Systems in Pharmaceutical ... described as single-use systems (SUS) or single-use ...
(Date:10/16/2014)... , Oct. 16, 2014 Curtis & ... under 3 weeks away from hosting their co-located ... Oral Drug Formulation Innovations Summit taking place ... San Diego, CA. November,s events ... organizations in streamlining the bioequivalence testing process, as well ...
(Date:10/16/2014)... PHILADELPHIA , Oct. 16, 2014 Ninety ... (ALL) who had relapsed multiple times or failed to ... an investigational personalized cellular therapy, CTL019, developed at the ... The results published today in The ... new data, which builds on preliminary findings presented at ...
Breaking Medicine Technology:PDA Offers Help in Applying Single-Use Systems to Bio/Pharma Operations 2Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 4Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 5Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 6
... Health Corp. (Nasdaq: WBMD ) today announced the ... amount of 2.50% Convertible Notes due 2018 (including $50 million ... full of the initial purchaser,s over-allotment option).  The notes were ... under the Securities Act of 1933.   The ...
... NEW YORK, Jan. 11, 2011 Reportlinker.com ... is available in its catalogue: ... Price cuts set to negatively impact both ... http://www.reportlinker.com/p0360216/Spain-Pharmaceutical-Market-Overview – Price-cuts-set-to-negatively-impact-both-branded-and-generics-companies.html ...
Cached Medicine Technology:WebMD Closes Offering of 2.50% Convertible Notes Due 2018 2Reportlinker Adds Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies 2
(Date:10/18/2014)... New York, New York (PRWEB) October 18, 2014 ... allege the IUD caused women to sustain serious injuries ... the uterus continue to mount in U.S. courts, Bernstein ... issued by the U.S. Judicial Panel on Multidistrict Litigation ... are now pending in the multidistrict litigation underway in ...
(Date:10/18/2014)... One major trend upcoming in this market is ... making efforts to encourage people to donate organs. The ... process more transparent and easy. , Analysts forecast the ... at a CAGR of 16.85 percent over the period ... drivers in the market is an increase in the ...
(Date:10/18/2014)... New York, New York (PRWEB) October 18, 2014 ... continue to mount in a mass tort litigation ... Pleas, Bernstein Liebhard LLP reports. According to court ... in the proceeding on behalf of Risperdal patients ... gynecomastia (male breast growth), due to their use ...
(Date:10/18/2014)... Oct. 18, 2014 (HealthDay News) -- Even determined dieters ... of healthy foods nearby, researchers say. Their new ... had metabolic syndrome (a combination of risk factors that ... And, all were told by their doctors to make ... The participants were involved in a clinical trial ...
(Date:10/18/2014)... is known to most people, ASP.NET hosting is a ... Cheap Hosting USA has compared many professional web ASP.NET ... JustHost are among the most reliable companies in the ... a good ASP.NET supplier. Actually, these companies have outperformed ... customer support. People can get the best web hosting ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 4Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 2Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 3Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 4Health News:Risperdal Lawsuits Mount, as Claims in Pennsylvania Litigation Near 900, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Mount, as Claims in Pennsylvania Litigation Near 900, Bernstein Liebhard LLP Reports 3Health News:Dieters May Be Thwarted by Absence of Healthy Foods 2
... News) -- Media multitasking -- the use of more than ... -- may have some positive effects, a new study suggests. ... which is especially common in young people and could include ... or social networking -- have received widespread publicity. But ...
... CINCINNATINew research at the University of Cincinnati (UC) ... a complex process that can provide cells with ... circumstances autophagy can protect tumor cells from chemotherapy, ... time in a hidden, dormant, metastatic state. ...
... , SUNDAY, April 15 (HealthDay News) -- A ... regions linked to fractures and osteoporosis. Variations in ... bone-weakening disease, the investigators reported in a new study published ... . The study authors added that their findings could ...
... appear to be rising, especially among high school students, ... is alarming and indicates more coaches and athletic trainers ... the game, according to researchers based at the University ... the number of football-related brain injuries with permanent disability ...
... Cancer is much more likely in the elderly than the ... disease and the often-toxic side effects of treatment. But ... The University of Texas Health Science Center at San Antonio shows ... younger patients can be used to help the elderly, with less ...
... , FRIDAY, April 13 (HealthDay News) -- In a new study ... of sun damage, middle schoolers showed evidence of levels of UV ... Not only can the technology spot who is most vulnerable ... noted, but it could also be used as a powerful deterrent ...
Cached Medicine News:Health News:Media Multitasking Might Have Mental Upside 2Health News:Specific inhibition of autophagy may represent a new concept for treatment of kidney cancer 2Health News:Certain Genetic Regions May Be Tied to Osteoporosis 2Health News:Football-related catastrophic brain injuries on the rise 2Health News:Football-related catastrophic brain injuries on the rise 3Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 2Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 3Health News:Even Young Teens Show Signs of Sun Damage 2Health News:Even Young Teens Show Signs of Sun Damage 3Health News:Even Young Teens Show Signs of Sun Damage 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: